Variant report

Variant	nsv596199
Chromosome Location	chr4:172922257-173035260
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr4:173009768-173010010	K562	blood:	n/a	n/a
2	ATF3	chr4:172964033-172964313	K562	blood:	n/a	n/a
3	ATF3	chr4:172963829-172964376	HCT-116	colon:	n/a	n/a
4	BHLHE40	chr4:172955266-172955458	GM12878	blood:	n/a	n/a
5	BHLHE40	chr4:173009843-173010043	K562	blood:	n/a	n/a
6	CBX3	chr4:173027059-173027430	K562	blood:	n/a	n/a
7	CBX3	chr4:173027118-173027368	K562	blood:	n/a	n/a
8	CCNT2	chr4:173033010-173033202	K562	blood:	n/a	n/a
9	CEBPB	chr4:172963919-172964070	K562	blood:	n/a	n/a
10	CEBPB	chr4:172963777-172964413	HCT-116	colon:	n/a	n/a
11	CEBPB	chr4:172963622-172964378	HCT-116	colon:	n/a	n/a
12	CEBPB	chr4:172963774-172964388	Hela-S3	cervix:	n/a	n/a
13	CEBPB	chr4:172982433-172982704	Hela-S3	cervix:	n/a	chr4:172982587-172982600 chr4:172982589-172982600 chr4:172982585-172982596 chr4:172982587-172982598
14	CEBPB	chr4:172967162-172967510	HepG2	liver:	n/a	chr4:172967347-172967358 chr4:172967303-172967314
15	CEBPB	chr4:172967177-172967498	IMR90	lung:	n/a	chr4:172967347-172967358 chr4:172967303-172967314
16	CEBPB	chr4:173004566-173004925	Hela-S3	cervix:	n/a	n/a
17	CEBPB	chr4:173001535-173001557	H1-hESC	embryonic stem cell:	n/a	n/a
18	CEBPB	chr4:172967170-172967455	Hela-S3	cervix:	n/a	chr4:172967347-172967358 chr4:172967303-172967314
19	CEBPB	chr4:172976992-172977221	HepG2	liver:	n/a	chr4:172977101-172977112
20	CEBPB	chr4:172967123-172967427	K562	blood:	n/a	chr4:172967347-172967358 chr4:172967303-172967314
21	CEBPB	chr4:172982512-172982741	HepG2	liver:	n/a	chr4:172982587-172982600 chr4:172982589-172982600 chr4:172982585-172982596 chr4:172982587-172982598
22	CEBPB	chr4:172967154-172967499	A549	lung:	n/a	chr4:172967347-172967358 chr4:172967303-172967314
23	CEBPB	chr4:173009876-173009993	K562	blood:	n/a	n/a
24	CHD1	chr4:173020701-173020722	H1-hESC	embryonic stem cell:	n/a	n/a
25	CHD2	chr4:172955323-172955408	GM12878	blood:	n/a	n/a
26	CTCF	chr4:172955243-172955517	T-47D	breast:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
27	CTCF	chr4:172955340-172955490	K562	blood:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
28	CTCF	chr4:172955300-172955450	Caco-2	colon:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
29	CTCF	chr4:172955300-172955450	GM12870	blood:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
30	CTCF	chr4:172955240-172955390	HRPEpiC	eye:	n/a	n/a
31	CTCF	chr4:172955180-172955578	HepG2	liver:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
32	CTCF	chr4:172955300-172955450	GM12875	blood:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
33	CTCF	chr4:172955300-172955450	HPF	lung:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
34	CTCF	chr4:172955320-172955470	SK-N-SH_RA	brain:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
35	CTCF	chr4:172955074-172955691	A549	lung:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
36	CTCF	chr4:172955300-172955450	GM12866	blood:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
37	CTCF	chr4:172955320-172955470	Caco-2	colon:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
38	CTCF	chr4:172955340-172955490	A549	lung:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
39	CTCF	chr4:173018695-173018728	LNCaP	prostate:	n/a	n/a
40	CTCF	chr4:172955320-172955470	NB4	blood:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
41	CTCF	chr4:172955340-172955490	HL-60	blood:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
42	CTCF	chr4:172955251-172955481	ECC-1	luminal epithelium:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
43	CTCF	chr4:172955277-172955511	GM12892	blood:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
44	CTCF	chr4:172955185-172955654	GM12878	blood:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
45	CTCF	chr4:172955300-172955450	Hela-S3	cervix:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
46	CTCF	chr4:172955300-172955450	AG10803	skin:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
47	CTCF	chr4:172955300-172955450	HRPEpiC	eye:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
48	CTCF	chr4:172955280-172955496	MCF-7	breast:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
49	CTCF	chr4:172955262-172955530	MCF-7	breast:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403
50	CTCF	chr4:172955280-172955430	GM12878	blood:	n/a	chr4:172955381-172955402 chr4:172955386-172955404 chr4:172955387-172955403

No.	Distal block	Cell Line	Cell type
1	chr4:172979164..172981714-chr4:172998153..173000134,2	K562	blood:
2	chr4:172968051..172969692-chr4:172971526..172973256,2	K562	blood:
3	chr4:171180744..171181463-chr4:172955220..172956289,3	MCF-7	breast:
4	chr4:172929694..172931384-chr4:173129671..173131846,2	K562	blood:
5	chr4:172988137..172989930-chr4:172993221..172995055,2	K562	blood:
6	chr4:172962947..172965633-chr4:172966859..172970006,3	K562	blood:
7	chr4:173013361..173016115-chr4:173021036..173022697,2	K562	blood:
8	chr4:172977943..172980712-chr4:172981081..172983923,2	K562	blood:
9	chr4:172923574..172925287-chr4:172926705..172928781,2	MCF-7	breast:
10	chr4:172962947..172965633-chr4:172966859..172970006,3	K562	blood:
11	chr4:173021131..173023311-chr4:173023529..173025605,2	K562	blood:
12	chr4:172979164..172981714-chr4:172998153..173000134,2	K562	blood:
13	chr4:172977943..172980712-chr4:172981081..172983923,2	K562	blood:
14	chr4:172988137..172989930-chr4:172993221..172995055,2	K562	blood:
15	chr4:172955374..172956340-chr4:173068552..173069236,2	MCF-7	breast:
16	chr4:173025369..173026870-chr4:173057043..173059254,2	K562	blood:
17	chr4:173021131..173023311-chr4:173023529..173025605,2	K562	blood:
18	chr4:173021211..173023179-chr4:173025772..173028444,2	K562	blood:
19	chr4:172978945..172981586-chr4:173074547..173076699,2	K562	blood:
20	chr4:172767155..172768332-chr4:172954944..172955895,5	MCF-7	breast:
21	chr4:172968051..172969692-chr4:172971526..172973256,2	K562	blood:
22	chr4:173021211..173023179-chr4:173025772..173028444,2	K562	blood:
23	chr4:172923574..172925287-chr4:172926705..172928781,2	MCF-7	breast:
24	chr2:166764007..166764674-chr4:172977172..172977832,2	MCF-7	breast:
25	chr4:173013361..173016115-chr4:173021036..173022697,2	K562	blood:
26	chr4:173007639..173009652-chr4:173056667..173058243,2	K562	blood:

Variant related genes	Relation type
GALNTL6	TF binding region
ENSG00000123607	chromatin interactions

Extended variants
information (count: 1862 )
Associated
traits (count: 73 )

Variant overlapped rSNPs/rCNVs (count:1862 , 50 per page) page: 1 2 3 4 5 6 7 ... 38

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs146857524	chr4:172929028-172929029	Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs115976206	chr4:172929047-172929048	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs72698919	chr4:172929081-172929082	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs140704642	chr4:172929093-172929094	Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs554734938	chr4:172929129-172929130	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs11941516	chr4:172929137-172929138	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
7	rs189258276	chr4:172929138-172929139	Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs192360866	chr4:172929164-172929165	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs79080447	chr4:172929183-172929184	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs10213288	chr4:172929205-172929206	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs575305886	chr4:172929243-172929244	Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs184775372	chr4:172929260-172929261	Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs188745148	chr4:172929265-172929266	Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs573015251	chr4:172929328-172929329	Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs72698922	chr4:172929357-172929358	Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs540916995	chr4:172929375-172929376	Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs181966699	chr4:172929426-172929427	Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs560579096	chr4:172929427-172929428	Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs573042579	chr4:172929436-172929437	Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs142985986	chr4:172929454-172929455	Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs565052491	chr4:172929502-172929503	Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs369069714	chr4:172929512-172929513	Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs186310820	chr4:172929563-172929564	Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs113131588	chr4:172929610-172929611	Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs76550304	chr4:172929611-172929612	Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs563097114	chr4:172929701-172929702	Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs190022500	chr4:172929752-172929753	Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs386682111	chr4:172929754-172929755	Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs570420192	chr4:172929755-172929756	Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs116056275	chr4:172929756-172929757	Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs376470890	chr4:172929765-172929766	Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs546583755	chr4:172929788-172929789	Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs566612807	chr4:172929803-172929804	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
34	rs370094268	chr4:172929813-172929814	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
35	rs535379825	chr4:172929836-172929837	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs1979931	chr4:172929844-172929845	Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
37	rs568745607	chr4:172929901-172929902	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
38	rs537938482	chr4:172929911-172929912	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
39	rs539721652	chr4:172929939-172929940	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
40	rs78118430	chr4:172929962-172929963	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
41	rs111262010	chr4:172929972-172929973	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
42	rs111558296	chr4:172930001-172930002	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs548471880	chr4:172930012-172930013	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs140718051	chr4:172930043-172930044	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs180792924	chr4:172930050-172930051	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs112495791	chr4:172930061-172930062	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs150100519	chr4:172930074-172930075	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs529701224	chr4:172930110-172930111	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs369708515	chr4:172930130-172930131	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs185454445	chr4:172930152-172930153	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:73)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Oral squamous cell carcinoma	17134496	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Wilms tumour	21544195	CNVD
Lung cancer	18438408	CNVD
Cancer	22429812	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Breast cancer	16272173	CNVD
Breast cancer	17133270	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Congenital anomalies of the kidney and urinary tract	20505237	CNVD
Testicular germ cell tumor	18059402	CNVD
Ovarian cancer	22174824	CNVD
Olfactory neuroblastoma	18408657	CNVD
Breast cancer	21785460	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Ewing''s sarcoma	17952124	CNVD
Breast cancer	21633010	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Cancer	20581869	CNVD
Hepatocellular carcinoma	16750200	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
abnormal development	18461090	CNVD
Esophageal squamous carcinoma	17470683	CNVD
Neuroblastoma	16790693	CNVD
Schizophrenia	23813976	CNVD
Lung cancer	16773561	CNVD
Colorectal cancer	16774939	CNVD
Myelofibrosis	22110671	CNVD
Developmental delay	22127048	CNVD
Glioblastoma multiforme	22286061	CNVD
Neuroblastoma	21899760	CNVD
Gastric adenocarcinoma	19115996	CNVD
Urothelial carcinoma	21177765	CNVD
Prostate cancer	22341455	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:131 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:172929000-172933400	Enhancers	iPS-18 Cell Line	embryonic stem cell
2	chr4:172929200-172930000	Enhancers	Brain Germinal Matrix	brain
3	chr4:172929400-172929800	Enhancers	HUES64 Cell Line	embryonic stem cell
4	chr4:172929400-172929800	Enhancers	iPS-15b Cell Line	embryonic stem cell
5	chr4:172929400-172930400	Enhancers	HUES48 Cell Line	embryonic stem cell
6	chr4:172929600-172930000	Enhancers	HUES6 Cell Line	embryonic stem cell
7	chr4:172929600-172930000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
8	chr4:172929600-172930800	Enhancers	iPS-20b Cell Line	embryonic stem cell
9	chr4:172929800-172930600	Enhancers	H9 Cell Line	embryonic stem cell
10	chr4:172929800-172930600	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
11	chr4:172929800-172931200	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
12	chr4:172930000-172930200	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
13	chr4:172930000-172933200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
14	chr4:172930400-172931000	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
15	chr4:172930600-172931200	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
16	chr4:172930600-172933200	Weak transcription	H9 Cell Line	embryonic stem cell
17	chr4:172930800-172931200	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
18	chr4:172931200-172932200	Enhancers	iPS-20b Cell Line	embryonic stem cell
19	chr4:172931200-172933800	Enhancers	ES-I3 Cell Line	embryonic stem cell
20	chr4:172931400-172932200	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
21	chr4:172931800-172932000	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
22	chr4:172931800-172932000	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
23	chr4:172932000-172932200	Enhancers	iPS-15b Cell Line	embryonic stem cell
24	chr4:172932000-172932400	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
25	chr4:172932000-172933400	Enhancers	HUES6 Cell Line	embryonic stem cell
26	chr4:172932200-172932400	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
27	chr4:172932200-172932600	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
28	chr4:172932200-172933800	Enhancers	HUES64 Cell Line	embryonic stem cell
29	chr4:172932400-172932600	Enhancers	Primary hematopoietic stem cells short term culture	blood
30	chr4:172932400-172932800	Enhancers	Dnd41	blood
31	chr4:172932400-172933600	Enhancers	HUES48 Cell Line	embryonic stem cell
32	chr4:172932400-172933600	Enhancers	iPS-15b Cell Line	embryonic stem cell
33	chr4:172932600-172933400	Enhancers	iPS-20b Cell Line	embryonic stem cell
34	chr4:172933200-172933600	Enhancers	H1 Cell Line	embryonic stem cell
35	chr4:172933200-172933600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
36	chr4:172933200-172933800	Enhancers	H9 Cell Line	embryonic stem cell
37	chr4:172938000-172939400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
38	chr4:172938800-172940200	Enhancers	HMEC	breast
39	chr4:172939200-172940000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
40	chr4:172946600-172947000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
41	chr4:172964000-172964600	Enhancers	Hela-S3	cervix
42	chr4:172965000-172965400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
43	chr4:172965400-172965600	Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
44	chr4:172965400-172965800	Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
45	chr4:172965400-172966200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
46	chr4:172965600-172965800	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
47	chr4:172965800-172966000	Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
48	chr4:172966000-172968000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
49	chr4:172966200-172968200	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
50	chr4:172968000-172968600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links